MDGL News
Madrigal Pharmaceuticals, Inc.
$427.39
+$2.18(+0.51%)
37
Overall
40
Value
27
Tech
44
Quality
Market Cap
$9.93B
Volume
441.25K
52W Range
$353.54 - $615.00
Target Price
$678.26
MDGL news: the latest Madrigal Pharmaceuticals, Inc. headlines, press releases and market updates, newest first.
Latest MDGL News
- Bank of America Securities Keeps Their Hold Rating on Madrigal Pharmaceuticals (MDGL)TipRanks Auto-Generated Intelligence Newsdesk · Nov 4, 2026
- Wells Fargo Releases a Buy Rating on Madrigal Pharmaceuticals (MDGL)TipRanks Auto-Generated Intelligence Newsdesk · Nov 4, 2026
- Barclays Remains a Buy on Madrigal Pharmaceuticals (MDGL)TipRanks Auto-Generated Intelligence Newsdesk · Nov 4, 2026
- Bank of America Securities Reaffirms Their Hold Rating on Madrigal Pharmaceuticals (MDGL)TipRanks Auto-Generated Intelligence Newsdesk · Oct 19, 2026
- Analysts Offer Insights on Healthcare Companies: Praxis Precision Medicines (PRAX) and Madrigal Pharmaceuticals (MDGL)TipRanks Newsroom · Oct 18, 2026
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | MDGL | $427.39 | +0.5% | 441.25K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Madrigal Pharmaceuticals, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW